RadNet (RDNT) President, CEO Howard Berger Sells 90 Shares

On June 16, 2026, Howard Berger, the President and CEO of RadNet, Inc., sold 90 shares of the company. This transaction was not part of a pre-planned trading program. RadNet trades on the NasdaqGM under the ticker RDNT.

RadNet, Inc. Stock Down 30.5%

Shares of NasdaqGM:RDNT are trading near $52.82. RadNet, Inc. has a market cap of approximately $4.15 billion. The company has a forward P/E ratio of 55.99 and a beta of 1.385, indicating a somewhat higher volatility compared to the market. The stock's 52-week range is between $50.76 and $85.84, with a 50-day moving average of $56.00 and a 200-day moving average of $68.41. RadNet also has a current ratio of 1.165 and a quick ratio of 1.049, suggesting moderate liquidity, while its debt-to-equity ratio stands at 142.999.

Recent Earnings

In its latest financial results, RadNet reported revenue of approximately $2.14 billion, showing a growth rate of 22.1%. Despite this, the company posted a negative net margin of 0.662% and a return on equity of 1.77%, reflecting ongoing challenges in profitability. The next earnings report is expected on August 6, 2026.

About RadNet, Inc.

RadNet, Inc. is a healthcare company based in Los Angeles, California, that provides outpatient diagnostic imaging services. The company operates through its Imaging Centers and Digital Health segments, offering a range of services such as MRI, CT scans, PET scans, and other imaging procedures. RadNet also develops AI-powered health informatics solutions to enhance radiology services. Founded in 1981, it employs around 11,000 people.

Bottom Line

Howard Berger's sale of RadNet shares is a notable event for investors tracking insider activities. RadNet operates in the dynamic healthcare diagnostics sector, which is reflected in its stock's volatility and the company's financial performance. As a reminder, insider transactions like this are disclosed after the fact and are not necessarily indicative of future performance.